Concepedia

Publication | Open Access

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

284

Citations

17

References

2022

Year

Abstract

EudraCT: 2011-002026-52; ClinicalTrials.gov Identifier: NCT01526135.

References

YearCitations

Page 1